Today: 9 April 2026
Subscribe
Browse Category

LSE:NWG.L 19 January 2026 - 3 March 2026

NatWest profit beats forecasts, lifts targets and rolls out £750m buyback — while NWG shares cling to 600p

NatWest profit beats forecasts, lifts targets and rolls out £750m buyback — while NWG shares cling to 600p

NatWest reported a 24% rise in 2025 pretax operating profit to £7.7 billion and announced a £750 million share buyback for early 2026. The bank lifted its 2028 return target and proposed a 51% higher annual dividend. Shares fell 2.55% Thursday after a volatile week following its £2.7 billion deal to acquire Evelyn Partners. Assets under management grew 20% to £58.5 billion before the deal.
13 February 2026
···
Lloyds share price in focus: Buyback filing and Halifax house-price jump set up the week ahead

Lloyds share price in focus: Buyback filing and Halifax house-price jump set up the week ahead

Lloyds Banking Group shares closed at 106.75 pence on Friday, up 0.9%, after disclosing a 10 million share buyback for cancellation. Halifax, owned by Lloyds, reported UK house prices rose 0.7% in January to £300,077. Investors are watching for UK banking news next week and monitoring mortgage pricing trends. The London market reopens Monday.
8 February 2026
····
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
7 February 2026
··
NatWest stock tries to bounce after BoE spooks UK banks — what to watch before earnings

NatWest stock tries to bounce after BoE spooks UK banks — what to watch before earnings

NatWest shares rose 0.7% to 654.6 pence early Friday, recovering some ground after a 6% drop Thursday triggered by the Bank of England’s split vote on rates. The BoE kept its rate at 3.75% but signaled possible cuts ahead. NatWest repurchased over 800,000 shares this week and will release annual results next Friday.
6 February 2026
·····
NatWest share price slips as BoE rate call, Evelyn Partners bid talk crowd the tape

NatWest share price slips as BoE rate call, Evelyn Partners bid talk crowd the tape

NatWest shares fell 0.2% to 690.4 pence in early London trading, after touching 676.4 pence. Investors are watching for the Bank of England’s rate decision at midday and reports that NatWest and Barclays will bid over £2 billion for Evelyn Partners. NatWest announced a £10 billion social housing funding package and confirmed it met a previous lending target early. Annual results are due Feb. 13.
5 February 2026
··
NatWest share price dips as traders weigh possible 2027 profit target lift

NatWest share price dips as traders weigh possible 2027 profit target lift

NatWest shares fell 0.45% to 664.6 pence in early London trading, pulling back after a sector rally pushed UK bank stocks to their highest since 2008. Reuters reported NatWest may raise its 2027 profitability target to 17% ahead of annual results due Feb. 13. The bank continued share buybacks, repurchasing nearly 797,000 shares on Jan. 27. Investors are watching for Fed and Bank of England policy signals this week.
28 January 2026
·
1 2

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop